oral+semaglutide+approval FDA approves first-ever oral GLP-1RA for obesity and chronic weight management. Meet Wegovy (semaglutide) tablets. https://www.prnewswire.com/news-releases/fda-approves-novo-nordisks-wegovy-pill-the-first-and-only- oral-glp-1-for-weight-loss-in-adults FDA Approves First ORAL GLP-1

This article addresses the importance of maintaining good Vitamin B12 levels and the benefits associated with Vitamin B12 injections

Many people see meaningful reductions in blood sugar and medication needs within weeks

Lead author Dr Ilaria Costantini (UCL Psychiatry) said: Binge eating disorder, where people regularly eat an excessive amount of food while feeling they have lost control, is common and highly impairing, affecting over 17 million people worldwide

In the SURPASS clinical trial program evaluating tirzepatide for type 2 diabetes and the SURMOUNT trials for weight management, insomnia was not identified as a statistically significant adverse event compared to placebo groups, based on published trial results